Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Elizabeth Plimack, MD, MS, Fox Chase Cancer Center, Philadelphia, PA, discusses the toxicity profiles and side effect management of first-line treatment options in renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.